Adnp+/− mice exhibited cognitive deficits, significant increases in pathological phosphorylated Tau compared with Adnp+/+ mice. CP201 treatment partially ameliorated cognitive deficits and reduced Tau hyperphosphorylation in the Adnp+/− mice. This evidence concerns the gene MAPT and Cognitive impairment.